Open in interactive viewer → charts, metric popovers & call review

TOYO Is Paying for Its U.S. Module Business With Its Best Margin

The cell line that generated 25%-plus gross margins has been voluntarily idled pending a December Commerce ruling — and management is now quoting contracted 2028 module prices above $0.40/watt
TOYO · Earnings Call · 2026-11-16

TOYO's third quarter looks, on the surface, like a business breaking. Revenue fell 4.8% year over year to $129.0 million, net income collapsed to $4.3 million from $22.6 million, and gross margin went from a 25.7% year-ago level — and 31.3% just one quarter earlier — to 16.6%. EPS of $0.10 against $0.66. That is the top of the tape.

The bottom of the tape tells a different story. Third-party revenue rose 57.3% to $112.1 million. Module shipments hit 277.4 megawatts in the quarter and 469 megawatts for the nine months. The company's nine-month revenue climbed 42.0% to $390.0 million, gross profit rose 83.4% to $106.2 million, and net income nearly doubled to $50.1 million. Adjusted EBITDA for the nine months was $102.1 million against a market capitalization of roughly $198 million.

The gap between those two paragraphs is the whole dossier: TOYO deliberately switched off its highest-margin product and let module mix absorb the blow.

The margin cliff was a choice, not a shortfall

Cell sales were $49.4 million in Q3 against $55.4 million of modules and $24.3 million of wafers, a business that only began in July. CFO Harada Yasunari attributed the margin compression to "the change in our sales mix as solar cell sales decreased and solar module sales increased." But the cell business didn't shrink because customers left. It shrank because TOYO stopped shipping.

Asked whether product was still flowing, Chief Strategy Officer Rhone Resch was unusually direct: “And so because that is sitting out there, there is uncertainty as to if those imports from Ethiopia would be tariffed or not. And so we are not bringing in cells because of that uncertainty.” — Rhone Resch, Executive or Senior Management · 2026-11-16

This is a company that generates 20%-plus margins on cells and "double digit" margins on modules, per Simon Shi, and it chose the double-digit business on purpose. Related-party revenue was $17.0 million in Q3, and Shi told the call that in 2027 “almost all of our revenue will be from third party.” — Liang Shi, Executive or Senior Management · 2026-11-16 The old VSUN-flavored captive channel is being retired just as the U.S. module franchise takes over.

A binary with two dates — and management gave two different ones

The circumvention case was initiated July 17. TOYO is a mandatory respondent, filed its questionnaire last week, and expects a preliminary determination. On the statutory deadline, Resch told Amit Dayal it was "scheduled to have a preliminary determination by December 17," then eleven components later told Philip Shen the statutory date was "December 10." Same call, same government action, two dates. Whatever the calendar, the substantive case rests on a single factual distinction that TOYO has been hammering for three quarters: “we do not use Chinese wafers at our facility in Ethiopia. All of them come from Indonesia. All of the polysilicon is either U.S. or coming from OCI in Malaysia.” — Rhone Resch, Executive or Senior Management · 2026-11-16 Prior solar circumvention cases, as Resch noted, turned on wafer origin — a Chinese wafer triggered tariffs, a non-Chinese one did not.

The CBP thread, meanwhile, has genuinely resolved. All detained shipments were released after a three-to-four-month review, and TOYO is applying for CTPAT certification. That keyword — detention — spiked in the prior quarter's language and has now slid down the transcript, replaced by cell supply and non-FEOC sourcing. The company has secured non-FEOC cells from outside Ethiopia to cover committed U.S. deliveries through 2027. The line is protected; the upstream is not.

What actually changed this quarter

Three things moved, and they matter more than the GAAP noise.

First, pricing went from poetry to contracts. In August, Resch was asked about post-Section-232 module pricing and demurred, calling $0.38 the likely floor and saying it was too early. Compare “a little bit too early right now to talk about, I think, the pricing structure of what we're going to see out of the 232.” — Rhone Resch, Executive (likely VP or similar, involved in strategy and government relations) · 2026-08-19 On this call, Shi gave a ladder: mid-$0.30s for first-half 2027 shipments, high-$0.30s for the second half, and for 2028, “I think 2028 will be more reflecting of the 20 -- sorry, Section 232 policy, which will be over $0.40. That's the range we are talking, over $0.40, $0.40 to $0.45.” — Liang Shi, Executive or Senior Management · 2026-11-16 That is contracted, not aspirational — roughly 20%-plus above the floor discussed in August, on a blended domestic/imported cell basis.

Second, the Section 45X credit finally has a receipt. For at least three consecutive calls the answer was that 45X was excluded from guidance and still under audit. In May, Resch: “The 45x credits are not in our guidance for but they do provide an upside.” — Rhone Resch, Senior Executive (likely COO or Head of U.S. Operations) · 2026-05-18 Now Shi reports “our first offset from the tax credit of last year has been approved.” — Liang Shi, Executive or Senior Management · 2026-11-16 Zero 45X in the Q3 number, so the 16.6% margin is a clean — and arguably understated — read on the module business.

Third, guidance went from deferred to absent. In August, Crocker Coulson said the company had “not reaffirmed it on the call today, and we're waiting for some clarity before we come back with an update to investors.” — Crocker Coulson, Investor Relations · 2026-08-19 That was a pause. This is a blackout:

Given the continuing uncertainty related to the Commerce circumvention inquiry and the Section 232 program, which principally affects cell shipment, we are not providing quarterly guidance for our solar cell business, specific guidance on revenue, net income or other metrics at this time.

Harada Yasunari, Executive · 2026-11-16

The one number management would commit to: Houston module capacity is "substantially committed for 2027" and will run at or near full capacity, with roughly $240 million of binding supply agreements signed since mid-June, and less than 20% of 2027 capacity held back deliberately to capture better pricing.

The $357 million question

The 1.5-gigawatt HJT line in Humble now carries a $357 million price tag and a pilot production target "no later than the first quarter of 2028" — a phrase that has drifted slightly from August's “pilot operation either at the end of Q4 2027 or the beginning of 2028.” — Rhone Resch, Executive (likely VP or similar, involved in strategy and government relations) · 2026-08-19 The balance sheet holds $74.0 million of cash and restricted cash, $64.9 million of it unrestricted, against nine-month operating cash flow of $35.2 million and $44.1 million of capex already spent. That is a $357 million build funded by a company with a $198 million market cap.

Resch's answer is the 45X credit, debt, operating cash flow, and "other nondilutive sources," with timing explicitly gated on financing availability. Investors should treat that gate as the real timeline, not the 2028 date.

What makes this unusual is the market's pricing. A business generating $102.1 million of nine-month adjusted EBITDA and $1.27 of nine-month EPS is valued at roughly a third of annualized EBITDA. The market is not underwriting the module franchise — it is pricing a regulatory coin-flip and a capital call. Worth noting: TOYO's themes are almost entirely company-unique. The broader tape's trade-policy complex — trade defense mechanism chatter, tariff-refund beneficiaries, onshoring plays like TE's import cells disclosure — provides a sympathetic backdrop, but nobody else in this reporting window is talking about an Ethiopian wafer-origin determination. This is a single-name binary wearing a sector costume.

The next six weeks decide it: the onshoring-plan guidance document expected in the Federal Register this week, the December 4 Section 232 effective date, and a preliminary circumvention determination due around December 10 to 17. If the wafer-origin precedent holds, TOYO gets its cell margins back and the 2027 story is a full-capacity module plant plus a reinstated 4-gigawatt Ethiopian cell line. If it doesn't, the company has already shown it can survive on double-digit module margins and a $0.40/watt 2028 price ladder — just not at 27% blended gross margin.